1. Home
  2. TDG vs BSX Comparison

TDG vs BSX Comparison

Compare TDG & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transdigm Group Incorporated

TDG

Transdigm Group Incorporated

HOLD

Current Price

$1,256.52

Market Cap

67.4B

Sector

Industrials

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$49.64

Market Cap

65.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDG
BSX
Founded
1993
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.4B
65.8B
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
TDG
BSX
Price
$1,256.52
$49.64
Analyst Decision
Buy
Strong Buy
Analyst Count
14
22
Target Price
$1,559.69
$93.18
AVG Volume (30 Days)
397.8K
17.5M
Earning Date
05-05-2026
04-22-2026
Dividend Yield
7.88%
N/A
EPS Growth
25.21
55.20
EPS
25.20
1.51
Revenue
$8,831,000,000.00
$9,076,000,000.00
Revenue This Year
$15.19
$11.85
Revenue Next Year
$8.64
$10.16
P/E Ratio
$49.79
$31.62
Revenue Growth
11.22
12.49
52 Week Low
$1,123.61
$42.20
52 Week High
$1,463.03
$109.50

Technical Indicators

Market Signals
Indicator
TDG
BSX
Relative Strength Index (RSI) 52.48 64.23
Support Level $1,249.33 $47.17
Resistance Level $1,283.44 $50.14
Average True Range (ATR) 35.69 1.54
MACD 3.65 0.68
Stochastic Oscillator 49.27 96.00

Price Performance

Historical Comparison
TDG
BSX

About TDG Transdigm Group Incorporated

TransDigm manufactures and services a broad set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses on buying up smaller firms that make proprietary aerospace products with substantial aftermarket demand. TransDigm regularly employs financial leverage to amplify its operating results.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: